摘要
血管紧张素转换酶2 (ACE2)是肾素–血管紧张素系统(RAS)的负调节因子,通过抑制Ang II并催化产生Ang-(1-7),起着保护血管、抑制炎症反应的作用。近年研究表明,在AS发生发展过程中,ACE2可以增加Ang-(1-7)的含量并增加体内超氧化物歧化酶的活性,从而保护内皮细胞免受炎症反应的影响,起到早期预防动脉粥样硬化的作用。现就ACE2对AS的治疗作用的潜在机制作一简要综述。以期为临床应用ACE2治疗AS提供参考。
Angiotensin converting enzyme 2 (ACE2) is a negative regulator of renin-angiotensin system (RAS). By inhibiting Ang II and catalyzing it to produce Ang-(1-7), ACE2 has effect in protecting blood vessel, inhibiting inflammatory reaction. Recent studies have shown that during the occurrence and development of AS, ACE2 can increase the content of Ang-(1-7) and increase the activity of superoxide dismutase in vivo, thus protecting endothelial cells from inflammatory response and playing an early role in preventing atherosclerosis. In order to provide reference for the clinical application of ACE2, this review briefly shows the potential mechanisms of ACE2 in the treatment of AS.
出处
《临床医学进展》
2022年第2期846-851,共6页
Advances in Clinical Medicine
